Standout Papers
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial (2003)
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002)
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
2016
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
2018 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Primary Prevention of Ischemic Stroke
2006
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
2008
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017
Cardiovascular Remodeling Induced by Passive Smoking
2009
Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
2017
Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure
2004
Doxazosin in benign prostatic hyperplasia: Effects on blood pressure and urinary flow in normotensive and hypertensive men
1995
The prevention of heart failure in minority communities and discrepancies in health care delivery systems
2004
Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics
2004
Cardiovascular prevention and blood pressure reduction
2003
British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary
2004
Hypertensive myocardial fibrosis
2005
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease
2003
Triglycerides and Cardiovascular Disease
2011
The safety of statins in clinical practice
2007
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE study)
2001
Inflammation and metabolic disorders
2006 StandoutNature
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
2009
A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly
2003
The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke
1999
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003
Sudden death and sleeping history among Finnish men
1991
Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study
2005
Recent hypertension trials
2005
Stroke prevention, blood cholesterol, and statins
2004
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects
2004
Wound repair and regeneration
2008 StandoutNature
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/Indapamide in hypertensive subjects: comparison with atenolol
2004
Effect of different antihypertensive drug classes on central aortic pressure
2004
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Prevention of heart failure
2002
Effect of the Magnitude of Lipid Lowering on Risk of Elevated Liver Enzymes, Rhabdomyolysis, and Cancer
2007
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
Management of High Blood Pressure in African Americans<subtitle>Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks</subtitle>
2003
Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
2008
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
The Study on Cognition and Prognosis in the Elderly (SCOPE)
2003
Guidelines for the Primary Prevention of Stroke
2010
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
2005
A randomised controlled pilot study of standardised counselling and cost-free pharmacotherapy for smoking cessation among stroke and TIA patients
2011
Recommendations for the use of home (self) and ambulatory blood pressure monitoring
1996
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Benefits from angiotensin-converting enzyme inhibitor ‘beyond blood pressure lowering’: beyond blood pressure or beyond the brachial artery?
2005
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
2006
The Disproportionate Impact of Hypertensive Cardiovascular Disease in African Americans: Getting to the Heart of the Issue
2004
Primary Prevention With Statins
2015
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy
2010
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study
2002
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
2005
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003 Standout
Diabetes and Atherosclerosis
2002 Standout
Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
2006
Impact of Systemic Hypertension on the Cardiovascular Benefits of Statin Therapy—A Meta-Analysis
2008
Atenolol in hypertension: is it a wise choice?
2004
Arterial stiffness and the systolic hypertension syndrome
2004
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
2009
Lifestyle factors and stroke risk: Exercise, alcohol, diet, obesity, smoking, drug use, and stress
2000
Original Papers. Success and Predictors of Blood Pressure Control in Diverse North American Settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
2011
Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients
2012
Inflammation in atherosclerosis
2002 StandoutNature
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Are we misunderstanding beta-blockers
2007
Statins and All-Cause Mortality in High-Risk Primary Prevention
2010
Safety of Aggressive Lipid Management
2007
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
2011
Insulin resistance and atherosclerosis
2006
Blood pressure screening, management and control in England
1998
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association
2018
Passive smoking as well as active smoking increases the risk of acute stroke
1999
Drug Insight: translating evidence on statin therapy into clinical benefits
2008
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
2003
HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events
2007
Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents
2003
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Mevalonate pathway: A review of clinical and therapeutical implications
2007
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
2004
Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension?
1998
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk
2003
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention
2005
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Cigarette Smoking as a Determinant of High-Grade Carotid Artery Stenosis in Hispanic, Black, and White Patients With Stroke or Transient Ischemic Attack
1998
Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events
2003
Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
2002
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Primary Prevention of Ischemic Stroke
2001
Usefulness of Pravastatin in Primary Prevention of Cardiovascular Events in Women
2008
Smoking Cessation and Decreased Risk of Stroke in Women
1993
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cessation of Smoking After First-Ever Stroke
2002
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack
2008
Smoking Cessation and the Risk of Stroke in Middle-aged Men
1995
Old antihypertensives and new diabetes
2004
Stroke mortality and morbidity attributable to passive smoking in Germany
2007
Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart Study.
1993
Cigarette Smoking and Other Risk Factors for Silent Cerebral Infarction in the General Population
1998
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
2004
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial
2001
“Systolic and diastolic dysfunction” in heart failure? Time for a new paradigm
2003
Statins for the primary prevention of cardiovascular disease
2013
Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy
2003
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia.
1994
Statins in Stroke Prevention and Carotid Atherosclerosis
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia
2010
Piezo1, a mechanically activated ion channel, is required for vascular development in mice
2014 StandoutNobel
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
2007 Standout
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus
2015
Announcement about ASCOT-LLA
2004
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes
2006
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004
Primary Prevention of Ischemic Stroke
2001
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Mechanisms of Mechanotransduction
2006
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
2016
Mechanisms of Diabetic Complications
2013 Standout
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial
2011
Stroke recurrence within 2 years after ischemic infarction.
1991
Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels.
1993
Blood Pressure Lowering in Type 2 Diabetes
2015
Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
2014
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions
2004
Management of High Blood Pressure in Blacks
2010
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
1991 Standout
Measuring agreement in method comparison studies
1999 Standout
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol
2004
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
2008
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
Blood Pressure and Stroke
2004
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
2016
Different Risk Factors for Different Stroke Subtypes
1999
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
2006
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout
Early high-dose lipid-lowering therapy to avoid cardiac events: a systematic review and economic evaluation
2009
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Cigarette Smoking, Cardiovascular Disease, and Stroke
1997
Systolic and diastolic blood pressure control in antihypertensive drug trials
2002
Works of Gareth Beevers being referenced
Meta-analysis of relation between cigarette smoking and stroke.
1989
Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy
2002
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy
2004
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial
2001
Ethnic differences in public health awareness, health perceptions and physical exercise: Implications for heart disease prevention
1996
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)
2004
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes
2008
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol
2001
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure
2008
The pathophysiology of hypertension
2001
Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.
1993
The relation of alcohol consumption to cardiovascular risk factors and stroke. The west Birmingham stroke project.
1993
Mortality in Patients of the Glasgow Blood Pressure Clinic
1986
Blood pressure measurement
1988
Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy
2005
Characteristics of 9194 Patients With Left Ventricular Hypertrophy
1998
Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes
2005
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout